Dr. Otani, et al, of Chubu Rousai HP of Nagoya, Japan, presented his abstract at the 103rd Annual Meeting of the Japanese Urological Association which took place April 18-21, 2015 in Kanazawa, Japan. Dr. Otani evaluated treatment efficacy of Low Intensity Extracorporeal Shockwave for ED treatment with the Renova (Direx) device. He concludes: "The number of sessions was 1/3 of 1st generation, meaning the burden of the patients and operators was drastically decreased. The scores of IIEF, SEP, EHS and GAQ questionnaires were improved 1 month post treatment and were sustained 6 mnths post-treatment. A general increase of 7.5 points in IIEF-EF was noticed without any side effects, making this technology safe and effective for treating Vasculogenic ED."
DirexGroup specializes in introducing innovative high-technology devices for urologists in all worldwide markets. DirexGroup, established nearly 30 years ago, has continuously extended its worldwide presence in numerous countries and markets. DirexGroup has put its emphasis on the field of urology and offers urologists and medical centers various equipment and service solutions to their clinical and economic needs. Our products are characterized by reliability, modularity and transportability combined with cost effectiveness and ease of use. A worldwide network of committed service centers assure competent support and maintenance. Contact DirexGroup at: email@example.com